Underrepresentation of women in new drug trials. Ramifications and remedies

E. L. Kinney; J. Trautmann; J. A. Gold; E. S. Vesell; R. Zelis

doi:10.7326/0003-4819-95-4-495

Underrepresentation of women in new drug trials. Ramifications and remedies

E. L. Kinney, J. Trautmann, J. A. Gold, E. S. Vesell, R. Zelis

Department of Medicine

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Abstract

Young women serve less frequently than young men as subjects in premarketing clinical drug trials. Moral, legal, and medical implications of this underrepresentation of women are considered. Risks of medical harm to female patients can increase because medication is withheld. Also, risks of toxicity increase when women receive certain new drugs only in the postmarketing phase. Remedies to increase participation of young, nonpregnant women in clinical trials are discussed.

Original language	English (US)
Pages (from-to)	495-499
Number of pages	5
Journal	Unknown Journal
Volume	95
Issue number	4
DOIs	https://doi.org/10.7326/0003-4819-95-4-495
State	Published - 1981

All Science Journal Classification (ASJC) codes

Internal Medicine

Access to Document

10.7326/0003-4819-95-4-495

Cite this

@article{c2014b4bde3b41d9a2592d8e25a97790,

title = "Underrepresentation of women in new drug trials. Ramifications and remedies",

abstract = "Young women serve less frequently than young men as subjects in premarketing clinical drug trials. Moral, legal, and medical implications of this underrepresentation of women are considered. Risks of medical harm to female patients can increase because medication is withheld. Also, risks of toxicity increase when women receive certain new drugs only in the postmarketing phase. Remedies to increase participation of young, nonpregnant women in clinical trials are discussed.",

author = "Kinney, {E. L.} and J. Trautmann and Gold, {J. A.} and Vesell, {E. S.} and R. Zelis",

year = "1981",

doi = "10.7326/0003-4819-95-4-495",

language = "English (US)",

volume = "95",

pages = "495--499",

journal = "Unknown Journal",

issn = "0042-1215",

number = "4",

}

TY - JOUR

T1 - Underrepresentation of women in new drug trials. Ramifications and remedies

AU - Kinney, E. L.

AU - Trautmann, J.

AU - Gold, J. A.

AU - Vesell, E. S.

AU - Zelis, R.

PY - 1981

Y1 - 1981

N2 - Young women serve less frequently than young men as subjects in premarketing clinical drug trials. Moral, legal, and medical implications of this underrepresentation of women are considered. Risks of medical harm to female patients can increase because medication is withheld. Also, risks of toxicity increase when women receive certain new drugs only in the postmarketing phase. Remedies to increase participation of young, nonpregnant women in clinical trials are discussed.

AB - Young women serve less frequently than young men as subjects in premarketing clinical drug trials. Moral, legal, and medical implications of this underrepresentation of women are considered. Risks of medical harm to female patients can increase because medication is withheld. Also, risks of toxicity increase when women receive certain new drugs only in the postmarketing phase. Remedies to increase participation of young, nonpregnant women in clinical trials are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0019409070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019409070&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-95-4-495

DO - 10.7326/0003-4819-95-4-495

M3 - Article

C2 - 7283301

AN - SCOPUS:0019409070

SN - 0042-1215

VL - 95

SP - 495

EP - 499

JO - Unknown Journal

JF - Unknown Journal

IS - 4

ER -

Underrepresentation of women in new drug trials. Ramifications and remedies

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this